Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AGOWA Genomics was a Berlin-based genomics service provider specializing in DNA sequencing and nucleic acid extraction. Founded in 1993, the company established itself as a leading European provider of molecular biological services for the pharmaceutical, biotech, and academic sectors. Its core offerings included Sanger sequencing, next-generation sequencing (NGS), and the development of proprietary magnetic bead-based extraction technologies. In 2005, AGOWA was acquired by the LGC Group, where it became the foundation for LGC's genomics division. Today, its technologies and expertise continue to support large-scale genomic projects globally under the LGC Biosearch Technologies brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AGOWA Genomics.